Megan Sippey

30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass

BACKGROUND Laparoscopic sleeve gastrectomy (SG) is gaining popularity over laparoscopic Roux-en-Y gastric bypass (LRYGB) within the United States. Data on readmissions after bariatric procedures are mostly based on LRYGB, with limited evidence regarding etiology of readmissions after SG. OBJECTIVES The aim of this study was to compare 30-day readmission rate and etiology after SG and LRYGB. SETTING American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) participating facilities METHODS Patients undergoing elective laparoscopic SG and LRYGB in 2012 and 2013 were identified from the ACS-NSQIP Participant Use Data File. Demographic characteristics, co-morbidities, and 30-day readmissions were analyzed. Multivariable logistic regression analysis evaluated variables with P<.1, using readmission as the dependent variable. RESULTS A total of 34,983 patients underwent bariatric surgery (46.0% SG, 54.0% LRYGB). Readmission was reported in 1773 (5.1%) patients. Readmission was more common after LRYGB compared with SG (6.1% versus 3.8%, P<.001, adjusted OR 1.59, 95% CI 1.44-1.76, P<.001). Nausea, vomiting, and dehydration were more commonly a reason for readmission after SG than LRYGB (30.4% versus 18.8%, P =<.001). Additionally, venous thromboembolism was a more frequent readmission cause for SG compared with LRYGB patients (7.2% versus 3.6%, P = .002). Postoperative pain, bleeding, intestinal obstructions, and wound occurrences were more commonly a readmission cause for LRYGB compared with SG. CONCLUSIONS Hospital readmissions are more common after LRYGB than SG. Reasons for readmission differ between procedures. Given the progressive increase in the proportion of bariatric patients undergoing SG, hospital programs that aim to decrease readmissions after bariatric surgery need to focus on prevention and control of postoperative nausea and dehydration.

Pulmonary embolism and gastrointestinal leak following bariatric surgery: when do major complications occur?

BACKGROUND Complications following bariatric surgery are uncommon but potentially life threatening. OBJECTIVES The aim of this study was to assess the timing of gastrointestinal leaks (GIL) and pulmonary embolism (PE) in patients undergoing bariatric surgery. SETTING Retrospective analysis of the nationwide American College of Surgeons National Surgical Quality Improvement Program database from 2006 to 2011. METHODS Data on patient demographic characteristics, baseline co-morbidities, procedural events, and postoperative occurrences were analyzed. Thirty-day morbidity was assessed. Median (interquartile range) and frequencies are reported. RESULTS We identified 71,694 bariatric surgery patients; median age was 45 years (range 36-54 yr), and median body mass index was 44.8 kg/m(2) (range 40.8-50.3 kg/m(2)). Laparoscopic Roux-en-Y gastric bypass was performed in 39,480 patients, laparoscopic adjustable band in 21,104, laparoscopic sleeve gastrectomy in 3225, open Roux-en-Y gastric bypass in 4243, duodenal switch in 1064, revisional surgery in 1182, and other procedures in 1396 patients. Of these patients, 95.2% had no complications. GIL was found in 441 (.6%), deep vein thrombosis in 184 (.3%), and PE in 134 (.2%). These complications occurred 10 (5-15), 13 (7-20), and 11 (4-19) days after surgery, respectively. GIL and PE developed after discharge in 275 (62.4%) and 96 (71.6%), respectively. Only 35 (26.1%) of the patients who developed PE had deep vein thrombosis. There were no differences in patient characteristics between the groups of early PE versus postdischarge PE. Patients diagnosed with in-hospital GIL were more obese with more severe systemic disease compared with patients with postdischarge diagnosis. CONCLUSIONS The majority of GILs and PEs after bariatric surgery occur after discharge. This finding goes against the routine use of contrast studies to rule out GIL. The risk of PE remains after discharge from bariatric surgery.

Chronic immunosuppressant use in colorectal cancer patients worsens postoperative morbidity and mortality through septic complications in a propensity-matched analysis

Chronic immunosuppressant use increases the risk of septic complications after colectomy; however, adverse effects on other organ systems remain poorly understood. The aim of this study was to evaluate the multisystem organ effect(s) of chronic immunosuppressant(s) in colorectal cancer patients.